
Brandon James Essink MD CPI
Hospital Medicine/Hospitalist, Healthcare Research and Healthcare Policy, Rural Health
PI @ DM Clinical Research
Join to View Full Profile
3319 N 107th StOmaha, NE 68134
Phone+1 402-933-6500
Fax+1 402-933-6501
Dr. Essink is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Brandon Essink, MD, based in Omaha, NE, specializes in Family Medicine with subspecialties in Hospital Medicine, Healthcare Research and Policy, and Rural Health. He completed his medical education and training at the University of Nebraska, including a fellowship in Vascular and Interventional Radiology. Currently a Principal investigator with DM Clinical Research, recently leaving the Chief Physician Officer role at Velocity Clinical Research, Dr. Essink has held several roles, including Physician at Bryan Medical Center and Director of Pediatric Vaccines at VaxNet. He has extensive experience in endoscopy, emergency medicine, clinical research, telemedicine, and rural family medicine. Dr. Essink has published multiple studies, primarily focused on vaccine safety and efficacy, in noted journals such as Human Vaccines & Immunotherapeutics and The Lancet. Infectious Diseases. His clinical trial involvement includes research on obesity, respiratory conditions, vaccines for influenza, COVID-19, and treatments for hyperhidrosis and osteoarthritis pain. Furthermore, he has earned honors such as the CMS Meaningful Use Stage 1 and 2 Certifications.
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Vascular and Interventional Radiology, 2003 - 2004
University of Nebraska Medical Center College of MedicineResidency, Family Medicine, 2001 - 2003
University of Nebraska College of MedicineClass of 2001
University of Nebraska-LincolnBS, 1997
Certifications & Licensure
FL State Medical License 2025 - 2028
GA State Medical License 2015 - 2028
MI State Medical License 2025 - 2028
AZ State Medical License 2024 - 2027
CO State Medical License 2024 - 2027
IA State Medical License 2020 - 2027
IN State Medical License 2024 - 2027
American Board of Family Medicine Family Medicine- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Medical and Practice Management (MPM) Client/Server, LSS Data Systems, 2013-2016
- CMS Meaningful Use Stage 2 Certification Medical and Practice Management (MPM) Client/Server, Medical Information Technology, Inc. (MEDITECH), 2013-2016
- CMS Meaningful Use Stage 1 Certification Medical and Practice Management (MPM) Client Server, LSS Data Systems, 2013-2016
Clinical Trials
- Study of Diclofenac Capsules to Treat Osteoarthritis Pain Start of enrollment: 2011 Oct 01
- Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) Start of enrollment: 2012 Feb 27
- Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged ≥...Marc Bonten, Brandon Essink, Nikita Hanning, Isabel Leroux-Roels, Cristina Masuet-Aumatell
Clinical Infectious Diseases. 2026-06-04 - Immunogenicity and safety of higher-dose cell-based adjuvanted quadrivalent influenza vaccines: Combined results of randomised, controlled dose-finding and dose-confir...Fred de Looze, Brandon J Essink, Josephine van Boxmeer, Coralie Andrade, Richard de Rooij
Vaccine. 2026-04-19 - 1 citationsImmunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.Emmanuel Feroldi, Mark J Mulligan, Kawsar R Talaat, Chen Sabrina Tan, Kristopher Paolino
The New England Journal of Medicine. 2026-04-09
Press Mentions
mRNA Vaccine Hesitancy? Midwestern Trial Site Organization Running Multiple Competitive Phase 3 Vaccine TrialsJuly 8th, 2021
Moderna Vaccine Shows 94.1% Efficacy in a Phase 3 Clinical TrialDecember 31st, 2020
Peer-Reviewed Report on Moderna COVID-19 Vaccine PublishesDecember 30th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:

















